This is the authors' abstract. We don't add key points for this paper.
Much confusion exists regarding the management of nodular goiters. The problem which confronts the clinician is whether to surgically remove asymptomatic thyroid nodules solely because of their possible malignancy. The statistics derived from series of surgically treated glands indicate a significant percentage of cancers in both clinically uninodular and clinically multinodular nontoxic goiters.¹As long as surgeons continue to be presented with the same selection of nodular goiters as has been responsible for these statistics, surgery for such goiters seems indicated. It has been pointed out that these data represent the findings in a selected group of nodular goiters, the selection having been performed by the patient himself, the family physician, and surgeon.²The unanswered question at present is what is the frequency of carcinoma in unselected nodular goiters. Sokal³and others have suggested that the percentage of malignancies in an unselected group of nodular goiters would
No takes yet. Share an insight, caveat, or question.
Stanley Slater (1956) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: